USVI Office of Cannabis Regulation Sets Sept. 15 Application Deadline

Deadline Closes Territory's First Licensing Round

The September 15, 2026, cutoff ends the U.S. Virgin Islands' inaugural cannabis licensing window, which opened in early 2026 under regulations finalized by the Office of Cannabis Regulation (OCR). Applications received after 5:00 p.m. Atlantic Standard Time won't be reviewed until a second round opens, according to the OCR's public notice. The agency didn't specify when that second window would begin.

The USVI legalized medical cannabis in 2019 under Act 8223, but regulatory delays postponed the licensing process until 2026. Starting in March 2026, the OCR began accepting applications for cultivation, manufacturing, testing laboratory, and dispensary licenses across the territory's three islands: St. Croix, St. Thomas, and St. John.

Application Volume and License Caps Remain Undisclosed

The OCR hasn't released data on how many applications were submitted during the six-month window or how many licenses the territory will issue in the first round. The 2019 statute doesn't impose numeric caps on cultivation or manufacturing licenses, but it limits dispensaries to one per 5,000 residents, suggesting a maximum of approximately 20 retail licenses territory-wide based on 2020 census figures.

Industry observers note that the lack of public application tallies makes it difficult to assess competitive pressure or predict approval rates. Published in February 2026, the OCR's enabling regulations require applicants to demonstrate financial capacity, facility plans, and community-impact statements—but the agency hasn't disclosed scoring rubrics or evaluation timelines.

Licensing Fees and Capitalization Requirements

Applicants paid non-refundable fees ranging from $5,000 for a dispensary application to $10,000 for a cultivation license, with annual renewal fees of $15,000 to $25,000 depending on license class. The OCR also requires proof of at least $250,000 in liquid capital for cultivation applicants and $100,000 for dispensary applicants. Some local business groups argued those figures would exclude smaller operators.

The territory's cannabis statute includes social-equity provisions prioritizing applicants with prior cannabis convictions or residency in historically disadvantaged communities. Yet the OCR hasn't published data on how many equity applicants submitted materials or whether equity scoring adjustments were applied uniformly.

Federal and Interstate Commerce Complications

The USVI operates under federal law as an unincorporated U.S. territory, meaning cannabis remains a Schedule I controlled substance within its borders despite local legalization. This creates banking and interstate-shipment obstacles identical to those faced by state-licensed operators. The territory's isolation also complicates supply-chain logistics: cultivation equipment, testing instruments, and packaging materials must be shipped from the mainland. That adds cost and delay.

For context on how U.S. territories navigate federal cannabis restrictions, see the CannIntel topic hub on U.S. Virgin Islands cannabis licensing.

The OCR's timeline for reviewing applications and issuing licenses remains unclear, leaving prospective operators in limbo as the territory's medical cannabis program inches toward operational launch seven years after statutory authorization.

What Comes Next for USVI Cannabis Operators

The OCR is expected to begin reviewing applications in Q4 2026, with initial license awards projected for early 2027, though no official timeline has been published. Approved operators will then need to pass facility inspections, obtain certificates of occupancy, and complete seed-to-sale tracking integration before commencing operations.

The territory's Department of Health must also finalize patient-registry rules and physician-certification protocols before dispensaries can legally serve customers. As of mid-September 2026, those regulations remained in draft form. Licensing delays, federal complications, and unresolved regulatory gaps mean the USVI's first legal cannabis sales are unlikely before mid-2027 at the earliest.